Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape
US$ 27,800.00
... ) $21,100. '2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business opportunities emerging in the global cancer diagnostics ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments ...
June 2015
1200 pages
Cancer Immunomodulators Market & Pipeline Insight 2020
US$ 2,000.00
... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...
June 2015
1000 pages
Global Cancer Biosimilars Market Opportunity Outlook
US$ 1,800.00
... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...
June 2015
550 pages
Global Prostate Cancer Therapeutics Market to 2020
US$ 1,000.00
... position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing ... “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market ...
May 2015
76 pages
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020
US$ 1,800.00
... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...
May 2015
190 pages
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)
US$ 6,900.00
... value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised Medicines in Oncology: Assessing Key Drivers and Challenges ... to development, access and implementation of personalised healthcare strategies. This survey provides US physician insights into personalised medicine within the oncology setting. By understanding what oncologists ...
May 2015
-
The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus
US$ 1,950.00
... the best results. The bottom line here is that cancer immunotherapies will revolutionise cancer treatment and the fortunes of the companies who bring ... -Sarcoma Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Paolo A. Ascierto, MD, Cancer Immunotherapy and Innovative Therapy Unit Istituto Nazionale ...
April 2015
-
European Pap Smear/HPV Market 2015
US$ 2,280.00
... , sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance ... test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies ...
April 2015
235 pages
US Thyroid Cancer Market: Trends and Opportunities (2015 – 2019)
US$ 800.00
... “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that ... titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into overall thyroid cancer sector of United States of America. The report includes detailed information on market size, installed ...
April 2015
75 pages
Cancer Nanomedicine Market & Pipeline Insight 2015
US$ 2,000.00
... cancer therapy can be achieved. “Cancer Nanomedicine Market & Pipeline Insight 2015” Report Highlight Nanomedicine for Cancer Therapies Cancer Nanoparticles Drug Delivery Systems Classification Mechanism of Cancer Nanomedicine Therapy Cancer Nanomedicine Clinical Pipeline Overview Cancer Nanomedicine ...
February 2015
220 pages
2015 Analysis of Cancer Diagnostic Technologies, and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, ...
January 2015
185 pages
2015 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 15,760.00
... during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging ... basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
January 2015
820 pages
2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Country Segment Forecasts, Supplier Shares, Innovative Technologies, Competitive Strategies
US$ 27,800.00
... -tailored to your specific information needs and budget. “2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, ... Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and ...
January 2015
1200 pages
2015 Emerging Cancer Diagnostic Tests and Companies Developing New Technologies
US$ 2,280.00
... Factors, Lymphokines, Immunohistochemical Stains and others. The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or ...
January 2015
260 pages
Dendritic Cell Cancer Vaccine Market & Clinical Insight
US$ 1,800.00
... Dendritic Cell Cancer Vaccines Dendritic Cell Vaccine Market Overview Market Dynamics (Drivers, Challenges & Future Prospects) Clinical Pipeline Insight by Phase, Indication & Company Dendritic Cell Cancer Vaccine in Clinical Pipeline: 52 Majority of Dendritic Cell Cancer Vaccine ...
January 2015
190 pages
Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015
US$ 1,500.00
... body to activate the immune cells. They identify these antigens as non-self and begin to search and eliminate cancerous cells from body ... ” Report Highlights: Introduction to Prostate Cancer Vaccine Mechanism of Prostate Cancer Vaccine Global Prostate Cancer Vaccine Clinical Trial Insight by Company, Country ...
January 2015
155 pages
Small Molecule Cancer Drug Clinical Pipeline Insight
US$ 2,400.00
... the treatment of Non-Small Cell Lung Cancer (NSCLC), Colon cancer, Breast and other cancers. Development of small molecule cancer drug generally ... Insight” Report Findings: Role of Small Molecule Drug in Cancer Treatment Mechanism of Small Molecule Cancer Drug Small Molecule Cancer Drugs Market Dynamics ...
January 2015
1650 pages
